Showing 1 - 3 results of 3 for search 'Nicola Long', query time: 0.03s Refine Results
  1. 1
    Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia

    Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia by Kyle A. Romine, Daniel Bottomly, Daniel Bottomly, William Yashar, William Yashar, Nicola Long, Nicola Long, Matthew Viehdorfer, Shannon K. McWeeney, Shannon K. McWeeney, Jeffrey W. Tyner, Jeffrey W. Tyner

    Published 2023-06-01
    Get full text
    Article
  2. 2
    NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia

    NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia by Yonghong Li, Jose Solis-Ruiz, Fei Yang, Nicola Long, Carmen H. Tong, Felicitas L. Lacbawan, Frederick K. Racke, Richard D. Press

    Published 2023-04-01
    Get full text
    Article
  3. 3
    Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency

    Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency by Patrick A. Flynn, Mark D. Long, Yoko Kosaka, Nicola Long, Jessica S. Mulkey, Jesse L. Coy, Anupriya Agarwal, Anupriya Agarwal, Anupriya Agarwal, Evan F. Lind, Evan F. Lind, Evan F. Lind

    Published 2024-03-01
    Get full text
    Article

Search Tools: